公告日期：2026-04-25

Stock Code: 603883 Company Abbreviation: LBX
LBX Pharmacy Chain Joint Stock Company
2025 Annual Report

(In case of any discrepancy between the Chinese and English versions of

this document, the Chinese version shall prevail.)

Important Notes

I. The Board of Directors, the directors and officers of the Company warrant that the contents of
thisAnnual Report are true, accurate and complete, free from false records, misleading statements
or major omissions, and that they will bear several and joint liability.

II. All directors of the Company attended the Board of Directors meetings.

III. Ernst & Young Hua Ming LLPissued a standard unqualified auditor's report for the

Company.

IV. Xie Zilong, the Company's principal, Chen Lishan, person in charge of
accounting work, and Shi Lei, the person in charge of accounting department (chief accountant)
declare as follows: We warrant the truthfulness, accuracy, and completeness of the financial report
in this Annual Report.

V. Profit distribution plan or plan for capitalization of capital reserves for the reporting period
approved by the resolution of the Board of Directors

As approved at the 14th meeting of the fifth Board of Directors upon deliberation on
April 22, 2026, the Company intends to distribute cash dividends of RMB 0.27 (tax-
inclusive) for every 10 shares to all shareholders based on the total share capital on the record
date for equity distribution. The Company will not issue bonus shares or convert capital
reserve into its share capital. As of March 31, 2026, the total share capital of the Company is
758,890,236 shares, and the Company intends to distribute cash dividends of RMB
204,900,364 (tax-inclusive). The total amount of cash dividends proposed by the Company
in 2025 (including tax) was RMB 311,144,997(including interim dividends of RMB
106,244,633 in 2025), accounting for 81.48% of the net profit……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。